Login / Signup

A and B antigen levels acquired by group O donor-derived erythrocytes following ABO-non-identical transfusion or minor ABO-incompatible haematopoietic stem cell transplantation.

Annika K HultJ H DykesJill R StorryMartin L Olsson
Published in: Transfusion medicine (Oxford, England) (2017)
The in vivo conversion of donor-derived blood group O RBC to ABO subgroup-like RBC after transfusion or minor ABO-incompatible HSCT raises the question of appropriate component selection. Based on these data, AB plasma should be transfused following ABO-incompatible HSCT.
Keyphrases
  • stem cell transplantation
  • high dose
  • red blood cell
  • cardiac surgery
  • electronic health record
  • sickle cell disease
  • acute kidney injury